用多基因酶抑制剂治疗先进的联合肝细胞 - 胆管癌
1Medical Oncology, Instituto Português de Oncologia de Coimbra Francisco Gentil, Coimbra, PRT.
Cureus
|March 4, 2024
概括
结合性肝细胞胆管癌 (cHCC-CC) 是一种罕见的肝癌. 本案例研究探讨了先进的转移性cHCC-CC的lenvatinib治疗方法,突出了这种侵袭性疾病的潜在治疗策略.
科学领域:
- 肝胆瘤学 肝胆瘤学
- 癌症生物学 癌症生物学
- 翻译医学是一种翻译医学.
背景情况:
- 结合性肝细胞胆管癌 (cHCC-CC) 由于其混合组织学和攻击性质,提出了诊断和治疗方面的挑战.
- 对于晚期或转移性cHCC-CC的最佳系统治疗仍未确定,往往需要使用已批准的治疗方案,用于肝细胞癌 (HCC) 或胆管癌 (CC).
相关概念视频
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Tumor Immunotherapy
524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524


